FAKTOR-OPTIONSSCHEIN - CARL ZEISS MEDITEC Share Price

Certificat

DE000SF3QR38

Delayed Deutsche Boerse AG 09:17:40 10/06/2024 BST
0.025 EUR -3.85% Intraday chart for FAKTOR-OPTIONSSCHEIN - CARL ZEISS MEDITEC
Current month+4.00%
1 month-55.17%
Date Price Change
10/06/24 0.025 -3.85%
07/06/24 0.026 0.00%
06/06/24 0.026 +4.00%
05/06/24 0.025 +4.17%
04/06/24 0.024 +4.35%

Delayed Quote Deutsche Boerse AG

Last update June 10, 2024 at 09:17 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer Société Générale Société Générale
WKN SF3QR3
ISINDE000SF3QR38
Date issued 19/08/2021
Strike 188.5
Maturity Unlimited
Parity 1 : 1
Emission price 10.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.36
Lowest since issue 0.022
Spread 0.01
Spread %28.57%

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
85.15 EUR
Average target price
103.9 EUR
Spread / Average Target
+21.98%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW